Oestrogen and progesterone receptor expression influences DNA ploidy and the proliferation potential of breast cancer cells

Anticancer Research

Volumn 23, Issue 3 C, 2003, Pages 3029-3039

  Andronas, M ^a   Dlay, S S ^a   Sherbet, G V ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Breast cancer; Cell cycle analysis; Disease free survival; DNA ploidy; Image cytometry; Metastasis; Oestrogen progesterone receptors; S phase fraction

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; METAPHASE; METASTASIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; FEMALE; HUMANS; PLOIDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0042122781     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Piva R, Rimondi AP, Hanau S, Maestri I, Alvisi A, Kumar VL and Delsenno L: Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor. Br J Cancer 61: 270-275, 1990.
2. Falette NS, Fuqua SA, Chamness GC, Cheah MS, Greene GL and McGuire WL: Oestrogen receptor gene methylation in human breast tumours. Cancer Res 50: 3874-3978, 1990.
3. Ottaviano YL, Issa JJ, Parl FF, Smith HS, Baylin SB and Davidson NE: Methylation of the oestrogen receptor gene CpG island marks loss of oestrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2555, 1994.
4. Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JPJ and Davidson NE: Methylation of oestrogen and progesterone receptor gene 5′ CpG islands correlates with lack of oestrogen and progesterone receptor gene expression in breast tumours. Clin Cancer Res 2: 805-810, 1996.
5. Chariot A and Castronovo V: Detection of HOX-A1 expression in human breast cancer. Biochem Biophys Res Commun 222: 292-297, 1996.
6. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R. Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE and Dale TC: Regulation of Msx-1, Msx-2, Bmp-2, and Bmp-4 during foetal a postnatal mammary gland development. Development 122: 2729-2737, 1996.
7. Sherbet GV: Genetic Recombination in Cancer. Elsevier/Academic Press, London, 2003.
8. Piva R, Kumar VL, Hanau S, Rimondi AP, Pansini S, Mollica G and Delsenno L: Abnormal methylation of oestrogen receptor gene and reduced oestrogen receptor RNA levels in human endometrial carcinomas. J Steroid Biochem Mol Biol 32: 1-4, 1989.
9. Li LC, Chui K, Nakajima K, Oh BR, Au HC and Dahiya R: Frequent methylation of oestrogen receptor in prostate cancer. Correlation with tumour progression. Cancer Res 60:702-706, 2000.
10. Issa JJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet 7: 536-540, 1994.
11. Issa JJ, Zehnbauer BA, Civin CI, Collector MJ, Sharkis SJ, Davidson NE, Kaufmannn SH and Baylin SB: The oestrogen receptor CpG island is methylated in most haematopoietic neoplasms. Cancer Res 56: 973-977, 1996.
12. Issa JJ, Baylin SB and Belinsky SA: Methylation of oestrogen receptor CpG island in lung cancer is related to the specific types of carcinogen exposure. Cancer Res 56: 3655-3658, 1998.
13. Yuan J, Hennessy C, Givan AL, Corbett IP, Henry JA, Sherbet GV and Lennard TWJ: Predicting outcome for patients with node negative breast cancer. A comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy. Br J Cancer 65: 461-465, 1992.
14. Azua J, Romeo P, Serrano M, Tello DM and Azua J: Prognostic value from DNA quantification by static cytometry in breast cancer. Analy Quant Cytol Histol 19: 80-86, 1997.
15. Gilchrist KW, Gray R, Vandrielkulker AMJ, Mesker WE, Ploem-Zaaijer JJ, Ploem JS, Taylor SG and Rormey DC: High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. Breast Cancer Res Treat 28: 1-8, 1993.
16. Sherbet GV and Lakshmi MS: The Genetics of Cancer. Academic Press, London and New York, 1997.
17. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM and McGuire WL: DNA ploidy, S-phase and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treatment 28: 9-20, 1993.
18. Esteva J, Bellotti M and Marchevsky AM: Neural networks for the estimation of prognosis in lung cancer. In: Artificial Neural Networks in Cancer Diagnosis, Prognosis and Patient Management. Eds. Naguib RNG, Sherbet GV. CRC Press, Boca Raton, FL, pp. 27-35, 2001.
19. Stal O, Sullivan S, Sun XF, Wingren S and Nordenskojld B: Simultaneous analysis of c-erbB2 expression and DNA content in breast cancer using flow cytometry. Cytometry 16: 160-168, 1994.
20. Sun XF, Cartensen JM, Stal O, Zhang H and Nordenskjold B: C-erbB2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma. APMIS 103: 309-315, 1995.
21. Ottersen GL, Christensen IJ, Larsen JK, Larsen J, Baldetorp B, Linden T, Hansen B and Andersen J: Carcinoma in situ of the breast: Correlation of histopathology to immunohistochemical markers and DNA ploidy. Breast Cancer Res Treat 60: 219-226, 2000.
22. Lakshmi MS and Sherbet GV: Measurement of DNA content and nuclear pleomorphism in metastatic variants of the B16 murine melanoma and hamster and lymphoma and its liver metastases using image analysis of techniques. Clin Exptl Metastasis 8: 553-566, 1990.
23. Hallouche F, Adams AE, Hinton O, Relf G, Lakshmi MS and Sherbet GV: Image processing for cell cycle analysis and discrimination in metastatic variant cell lines of the B16 melanoma. Pathobiology 60: 76-81, 1992.
24. Berek JS, Martinezmaza O, Hamilton T, Trope C, Kaern J, Baak J and Rustin GJS: Molecular and biological factors in the pathogenesis of ovarian cancer. Annals Oncol 4: 3-16, 1993.
25. Cheng CL and Van Ness JW: Statistical Regression with Measurement Error. Oxford University Press, Inc., 1999.
26. Longford NT: Random Coefficient Models. Oxford University Press, Inc., 1993.
27. Kattan MW, Hess KR and Beck JR: Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression. Computers and Biomedical Research 31: 363-373, 1998.
28. Schwarzer G, Vach W and Schumacher M: On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Statistics in Medicine 19: 541-561, 2000.
29. Naguib RNG, Neal DE and Hamdy FC: Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study. Brit J Cancer 8: 246-250, 1998.
30. Spiethoff A, Schenck A and Bohrer M: Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast cancer. J Cancer Res Clin Oncol 126: 707-710, 2000.
31. Leers MPG, Schutte B, Theunissen PHMH, Ramaekers FCS and Nap M: A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinoma. An objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single tube assay. Human Pathol 31: 584-592, 2000.
32. Boman K, Maentausta O, Backstrom T, Strang P and Stendahl U: Sex steroid hormones and receptors in relation to S-phase fraction and ploidy levels in endometrial carcinoma. Anticancer Res 15: 999-1002, 1995.
33. Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T and Machara Y: DNA ploidy and its clinical implications in gastric cancer. Surgery 131: S63-S70, 2000.
34. Oya R and Ikemura K: Can flow cytometrically determined DNA ploidy and S-phase fraction predict regional metastasis in squamous cell carcinoma of the oral cavity? Head Neck 24: 136-142, 2002.